| Nov 13 |
Clene GAAP EPS of -$1.22 beats by $0.07, revenue of $0.09M misses by $0.01M
|
| Nov 13 |
Clene Reports Third Quarter 2024 Financial Results and Recent Operating Highlights
|
| Oct 11 |
IBN Coverage: Clene (NASDAQ: CLNN) Closes $7.3M Registered Direct Offering and Concurrent Private Placements
|
| Oct 5 |
Independent Chairman of the Board of Clene David Matlin Buys 26% More Shares
|
| Oct 3 |
IBN Coverage: Clene (NASDAQ: CLNN) Closes on Direct Offering, Concurrent Private Placements Totaling $7.3M
|
| Oct 2 |
IBN Coverage: Clene (NASDAQ: CLNN) Announces Series of Direct Offerings, Concurrent Private Placements
|
| Oct 1 |
Clene Announces Closing of $7.3 Million Registered Direct Offering and Concurrent Private Placements and Amendment of Debt Facility
|
| Sep 26 |
IBN Coverage: Clene (NASDAQ: CLNN) to Discuss CNM-Au8(R) Data FDA Leadership
|
| Sep 16 |
Clene Granted In-Person Meeting With FDA Senior Leadership to Discuss CNM-Au8 Biomarker and Related Clinical and Survival Data
|
| Sep 4 |
IBN Coverage: Clene (NASDAQ: CLNN) Management to Present at H.C. Wainwright Investment Conference
|
